SAFTY

Clinical trials for SAFTY explained in plain language.

Never miss a new study

Get alerted when new SAFTY trials appear

Sign up with your email to follow new studies for SAFTY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New injection Y-3 put to the test: will it interfere with common medications?

Knowledge-focused Completed

This completed Phase 1 trial in 24 healthy Chinese adults aimed to see if a new drug called Y-3 (given as an injection) changes how the body processes three common medications: repaglinide (for diabetes), warfarin (a blood thinner), and omeprazole (for heartburn). Participants to…

Matched conditions: SAFTY

Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused

Last updated May 11, 2026 20:48 UTC

SAFTY

Get alerted when new SAFTY trials appear

New injection Y-3 put to the test: will it interfere with common medications?